Document is current
Any future updates will be listed below
-
Authors
Knudsen, Lenette
Andersen, Gregers Stig
Joensen, Lene Eide
Diaz, Lars Jorge
Clemmensen, Kim Katrine Bjerring
Nordin, Lone Lindegaard
Jessen, Anna
Nexø, Mette Andersen
Lomborg, Kirsten
Jørgensen, Marit Eika
Hansen, Dorte Lindqvist
- License Information
-
More Information
Article History
Received: 2 March 2023
Accepted: 3 November 2024
First Online: 18 November 2024
Declarations
:
: This study was conducted according to the guidelines in the Declaration of Helsinki. The study was approved by the Danish Data Protection Agency P-2019–338. The Danish Committee on Health Research Ethics assessed that ethical approval was not required for this study according to the Danish Act on Research Ethics Review of Health Research Projects (H-18009189). Interested and eligible individuals with diabetes and psychiatric disorder were given written and verbal information about the study before giving oral and written informed consent to participate.
: Not applicable.
: LEJ, LLN, AJ, MAN, KL, and DLH have no conflicts of interest to declare. LK, GSA and KKBC owns shares in Novo Nordisk A/S. LJD, KKBC and GSA are currently employed by Novo Nordisk A/S. During contribution to the manuscript, LJD, KKBC, and GSA were employed by Steno Diabetes Center Copenhagen. MEJ holds shares in Novo Nordisk, and has received research grants from AMGEN, Astra Zeneca, Boehringer Ingelheim, Novo Nordisk, and Sanofi Aventis.
